MetLife Investment Management
CDNA icon

MetLife Investment Management’s CareDx CDNA Stock Holding History

MetLife Investment Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$853K Buy
29,915
+894
+3% +$19.5K ﹤0.01% 1605
2026
Q1 		$504K Sell
29,021
-370
-1% -$7K ﹤0.01% 1753
2025
Q4 		$554K Sell
29,391
-2,680
-8% -$44.9K ﹤0.01% 1744
2025
Q3 		$466K Hold
32,071
– – ﹤0.01% 1840
2025
Q2 		$627K Buy
32,071
+1,333
+4% +$23.7K ﹤0.01% 1574
2025
Q1 		$546K Sell
30,738
-296
-1% -$6.38K ﹤0.01% 1689
2024
Q4 		$664K Buy
31,034
+2,134
+7% +$51.9K ﹤0.01% 1637
2024
Q3 		$902K Sell
28,900
-1,444
-5% -$35.9K 0.01% 1450
2024
Q2 		$471K Buy
30,344
+2,759
+10% +$33.3K ﹤0.01% 1748
2024
Q1 		$292K Hold
27,585
– – ﹤0.01% 1972
2023
Q4 		$331K Hold
27,585
– – ﹤0.01% 1934
2023
Q3 		$193K Hold
27,585
– – ﹤0.01% 2233
2023
Q2 		$234K Hold
27,585
– – ﹤0.01% 2176
2023
Q1 		$252K Hold
27,585
– – ﹤0.01% 2083
2022
Q4 		$315K Hold
27,585
– – ﹤0.01% 1949
2022
Q3 		$469K Hold
27,585
– – ﹤0.01% 1688
2022
Q2 		$593K Hold
27,585
– – ﹤0.01% 1545
2022
Q1 		$1.02M Buy
27,585
+9,938
+56% +$387K 0.01% 1308
2021
Q4 		$803K Hold
17,647
– – 0.01% 1225
2021
Q3 		$1.12M Hold
17,647
– – 0.01% 1070
2021
Q2 		$1.62M Sell
17,647
-1,254
-7% -$99.7K 0.01% 957
2021
Q1 		$1.29M Hold
18,901
– – 0.01% 1025
2020
Q4 		$1.37M Sell
18,901
-1,567
-8% -$90.8K 0.01% 991
2020
Q3 		$777K Buy
20,468
+1,672
+9% +$56.5K 0.01% 1154
2020
Q2 		$666K Hold
18,796
– – 0.01% 1225
2020
Q1 		$410K Hold
18,796
– – 0.01% 1316
2019
Q4 		$405K Hold
18,796
– – ﹤0.01% 1573
2019
Q3 		$425K Hold
18,796
– – ﹤0.01% 1513
2019
Q2 		$676K Sell
18,796
-29,444
-61% -$942K 0.01% 1306
2019
Q1 		$1.52M Buy
48,240
+32,160
+200% +$937K ﹤0.01% 1419
2018
Q4 		$404K Hold
16,080
– – ﹤0.01% 1503
2018
Q3 		$464K Hold
16,080
– – ﹤0.01% 1587
2018
Q2 		$197K Buy
+16,080
New +$184K ﹤0.01% 1925

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MetLife Investment Management's CDNA Position: Q2 2026 in Review

MetLife Investment Management increased its CareDx (CDNA) stake by 3.1% in Q2 2026, buying an estimated $19.5K and bringing the position to 29,915 shares worth $853K. The position accounts for ﹤0.01% of the portfolio, ranked #1605.

MetLife Investment Management first reported a position in CDNA in Q2 2018 and has held it in 33 quarters since. The position peaked at $1.62M in Q2 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • MetLife Investment Management held 29,915 shares of CareDx worth $853K as of Q2 2026.
  • MetLife Investment Management bought 894 CareDx shares in Q2 2026, an estimated $19.5K.
  • CareDx made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1605 holding.
  • MetLife Investment Management first reported a position in CareDx in Q2 2018 and has held it in 33 quarters since.
  • MetLife Investment Management's CareDx position peaked at $1.62M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.